How Often Can You Take Semaglutide, and What Does the Evidence Say?

What the STEP programme established about dosing frequency

The once-weekly interval for semaglutide isn't arbitrary. The STEP 1 trial, published in the New England Journal of Medicine, ran 68 weeks and built its entire protocol around a fixed seven-day injection cycle, titrating the dose from 0.25 mg upward while keeping the interval constant throughout. That design produced an average body-weight reduction of around 15% at the 2.4 mg maintenance dose. Regulators reviewed that data, and the weekly schedule is now part of the UK marketing authorisation for Wegovy.

What this means practically is that frequency and dose are separate things. The day of the week you inject stays the same from your first pen to your last. The strength changes. Your prescriber steps the dose up roughly every four weeks, giving your body time to adjust before increasing further. If you want a fuller explanation of how often you can take Wegovy and why the interval is fixed, that guide covers the licensed schedule and what happens if you miss or delay a dose. Trying to inject more often than once weekly does not accelerate results and increases the risk of side effects; trying to inject less often than weekly moves outside the licensed schedule.

The NHS medicines page for semaglutide describes the schedule in straightforward terms and is worth a read before your first pen arrives. A quick habit worth building: mark the same day in your phone calendar for every week of treatment, with a short reminder the evening before so the pen comes out of the fridge in time.

How the titration steps work without changing your injection day

The UK maintenance pathway runs 0.25 mg, then 0.5 mg, then 1.0 mg, then 1.7 mg, then 2.4 mg, with each step lasting roughly four weeks. Since April 2026, a higher 7.2 mg dose is also approved for eligible patients via a dedicated single-dose pen. None of those changes touch the weekly interval.

What does change is what your body experiences. Nausea, for instance, tends to be most noticeable in the first week or two at a new dose level and often settles once you have been on that strength for a while. If side effects are difficult at a given dose, your prescriber may decide to stay there longer before stepping up rather than rushing to the next strength. That decision sits with the clinician, not a fixed calendar.

If you are curious whether semaglutide's eligibility criteria apply to you, the full eligibility guide runs through the licensed BMI thresholds and weight-related conditions in detail. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance, and those details are covered there.

The oral formulation and why its frequency rule is completely different

Wegovy tablets (approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK) are taken once a day, not once a week. That difference matters if you are considering switching or comparing the two options.

The tablet schedule also has strict timing requirements. It goes in first thing in the morning, on an empty stomach, with a small amount of plain water. You then wait at least 30 minutes before food, coffee or other medicines. The reason is absorption: the co-formulation needs that window to work. Missing the timing does not mean taking a second tablet; it means waiting until the following morning.

The titration ladder for the tablet is also separate: 1.5 mg, 4 mg, 9 mg, then 25 mg maintenance, each step about a month apart. The strengths used in the Rybelsus diabetes tablet (3 mg, 7 mg, 14 mg) are completely different products and should not be confused with the Wegovy weight-loss tablet steps. Our Wegovy overview covers both the injection and tablet options, including what to expect from each formulation.

If cost is a factor in deciding between the injection and the tablet, the Wegovy cost breakdown explains what the market currently looks like and what a transparent private price should include.

What happens if you miss a dose or want to change your injection day

Life moves. Holidays, illness, and busy weeks mean doses sometimes get missed. The rule in the licensed guidance is practical: if fewer than five days have passed since your scheduled injection, take it as soon as you remember, then continue on your usual day. If five days or more have passed, skip that dose entirely and wait for your next scheduled day. Do not double up.

Changing your injection day is possible if your lifestyle needs it. You can shift the day forward or back, provided the gap between two consecutive injections is at least four days. Once changed, stick to the new day. Confirm the specifics with your prescriber or check the Patient Information Leaflet, because the exact wording for your pen matters.

Interactions with other medicines occasionally affect semaglutide decisions too. If you take levothyroxine, for example, the timing of your thyroid tablet relative to your injection day is worth discussing with a clinician. The guide on semaglutide and levothyroxine covers what is currently known. For broader questions about your BMI and eligibility, the BMI guide for semaglutide is a useful next step.

If you would like a clinician to review your specific situation and history, speak to our prescribers through a free consultation. Every submission is reviewed personally, the same day, by a GPhC-registered Independent Prescriber.